Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oscar A Ortega-Rivera

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
ACS Nano|March 4, 2020
Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active IngredientsPaul L Chariou, Oscar A Ortega-Rivera, Nicole F Steinmetz
Advanced Therapeutics|September 20, 2021
A single-dose, implant-based, trivalent virus-like particle vaccine against "cholesterol checkpoint" proteinsOscar A Ortega-Rivera, Jonathan K Pokorski, Nicole F Steinmetz
Bioconjugate Chemistry|October 3, 2022
Multivalent Display of ApoAI Peptides on the Surface of Tobacco Mosaic Virus Nanotubes Improves Cholesterol EffluxMatthew D Shin, Oscar A Ortega-Rivera, Nicole F Steinmetz
Nanomedicine : Nanotechnology, Biology, and Medicine|June 21, 2022
Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coatChristian Isalomboto Nkanga, Oscar A Ortega-Rivera, Nicole F Steinmetz
Nano Today|October 20, 2023
Two decades of vaccine development against atherosclerosisMiguel A Moreno-Gonzalez, Oscar A Ortega-Rivera, Nicole F Steinmetz
Vaccines|January 22, 2021
A Scalable Manufacturing Approach to Single Dose Vaccination against HPVShuai Shao, Oscar A Ortega-Rivera, Sayoni Ray, et al.
Journal of Materials Chemistry. B|March 2, 2023
A co-formulated vaccine of irradiated cancer cells and cowpea mosaic virus improves ovarian cancer rejectionZhongchao Zhao, Oscar A Ortega-Rivera, Young Hun Chung, et al.
Biomacromolecules|February 9, 2022
Dissolving Microneedle Delivery of a Prophylactic HPV VaccineSayoni Ray, David M Wirth, Oscar A Ortega-Rivera, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 29, 2023
Melt Processing Virus-Like Particle-Based Vaccine Candidates into Biodegradable Polymer ImplantsArmando A Puente, Oscar A Ortega-Rivera, David M Wirth, et al.
Advanced Therapeutics|December 26, 2022
A single-dose Qβ VLP vaccine against S100A9 protein reduces atherosclerosis in a preclinical modelOscar A Ortega-Rivera, Matthew D Shin, Miguel A Moreno-Gonzalez, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
ACS Nano|March 4, 2020
Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active IngredientsPaul L Chariou, Oscar A Ortega-Rivera, Nicole F Steinmetz
Advanced Therapeutics|September 20, 2021
A single-dose, implant-based, trivalent virus-like particle vaccine against "cholesterol checkpoint" proteinsOscar A Ortega-Rivera, Jonathan K Pokorski, Nicole F Steinmetz
Bioconjugate Chemistry|October 3, 2022
Multivalent Display of ApoAI Peptides on the Surface of Tobacco Mosaic Virus Nanotubes Improves Cholesterol EffluxMatthew D Shin, Oscar A Ortega-Rivera, Nicole F Steinmetz
Nanomedicine : Nanotechnology, Biology, and Medicine|June 21, 2022
Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coatChristian Isalomboto Nkanga, Oscar A Ortega-Rivera, Nicole F Steinmetz
Nano Today|October 20, 2023
Two decades of vaccine development against atherosclerosisMiguel A Moreno-Gonzalez, Oscar A Ortega-Rivera, Nicole F Steinmetz
Vaccines|January 22, 2021
A Scalable Manufacturing Approach to Single Dose Vaccination against HPVShuai Shao, Oscar A Ortega-Rivera, Sayoni Ray, et al.
Journal of Materials Chemistry. B|March 2, 2023
A co-formulated vaccine of irradiated cancer cells and cowpea mosaic virus improves ovarian cancer rejectionZhongchao Zhao, Oscar A Ortega-Rivera, Young Hun Chung, et al.
Biomacromolecules|February 9, 2022
Dissolving Microneedle Delivery of a Prophylactic HPV VaccineSayoni Ray, David M Wirth, Oscar A Ortega-Rivera, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 29, 2023
Melt Processing Virus-Like Particle-Based Vaccine Candidates into Biodegradable Polymer ImplantsArmando A Puente, Oscar A Ortega-Rivera, David M Wirth, et al.
Advanced Therapeutics|December 26, 2022
A single-dose Qβ VLP vaccine against S100A9 protein reduces atherosclerosis in a preclinical modelOscar A Ortega-Rivera, Matthew D Shin, Miguel A Moreno-Gonzalez, et al.
Pageof 2